Islet xenografts from porcine donors can reverse diabetes in experimental animal models and may be an alternative to human islet transplantation. We have recently reported the ability of porcine islets encapsulated in a double layer of hydrophilic agarose to maintain in vitro functional ability for >6 months. Although β-cells are capable of adapting their secretory capacity in response to glucose levels, evidence has shown that prolonged hyperglycemia can compromise this ability. The aim of the present study was to determine the effects of diet manipulation on the long-term regulation of blood glucose levels, and the preservation of functional islet in the macrobeads. Twenty-one streptozotocin-induced diabetic Wistar-Furth male rats were randomly assigned to two diets containing 64% carbohydrate (CHO) or 20% CHO. Groups of five to six animals assigned to either diet were implanted with either empty (EM) or porcine islet-containing macrobeads (PIM) and followed for 333 days. Observations included general condition, body weight, blood glucose, and food and water intakes. Monthly blood samples were collected for insulin and C-peptide analysis. The 20% CHO diet significantly lowered blood glucose values when compared with those of the 64% CHO groups for both the empty (14.94 ± 0.41 vs. 16.26 ± 0.42 mmol/L, respectively, p < 0.001) and islet macrobead recipients (12.88 ± 0.39 vs. 15.57 ± 0.85 mmol/L, respectively, p < 0.001). The different diets, however, had no statistically significant effects on the preservation of islet mass in the macrobead. Serum porcine C-peptide was detected throughout the experiment in animals receiving porcine islet macrobeads, regardless of diet. Diabetic rats fed a low carbohydrate level diet and transplanted with porcine islet macrobeads had improved total tissue glucose disposal and improved clinical parameters associated with diabetes.
INTRODUCTION
be or becoming manageable, the use of porcine islets in the treatment of human diabetes now appears to be a realistic objective. The use of animal-derived cells and organs for transplantation to replace missing physiological function in
In an effort to address both the biological safety and immune rejection challenges facing xenotransplantation humans such as the lack of insulin for glucose control in type 1 diabetes is a promising alternative to the use in the treatment of insulin-dependent diabetes, The Rogosin Institute has designed a two-layer 6-8-mm-diameof human donor tissue as a replacement source, because the supply of the latter is very limited. With a similar ter ovoid agarose macrobead that not only enables the detection over time of any microbiological contamiphysiology to that of humans, including an insulin molecule that differs by only one amino acid, and their virtunants, but also provides a protective barrier for porcine islets against a direct xenogeneic immunologic host really unlimited availability, pigs are widely considered to be the most likely animal donor for the cellular replacesponse. The islets themselves are embedded within the inner layer of agarose (1% concentration), which enment of pancreatic islets to treat type 1 diabetes. With many of the concerns regarding the safety and immunoables their maintenance in culture for at least 2 years. The outer layer of agarose, which is more concentrated logical aspects of xenotransplantation now considered to (5%), provides structural integrity to the macrobead and in the metabolic demands made on islets, some form of carbohydrate restriction is a key candidate for dietary also serves as a protective barrier against the host immune system, thus enabling the host to avoid the necescontrol of diabetes. In fact, before the discovery of insulin, dietary carbohydrate restriction was the recomsity of immunosuppressive agents.
As previously reported, xenografts of porcine and rat mended treatment for diabetes management. Diets containing 50-60% calories from carbohydrates have been islets embedded in the agarose-agarose macrobeads have been shown to normalize blood glucose in spontathe standard recommendation for patients with type 2 diabetes and metabolic syndrome (18) . Dietary carbohyneously diabetic rodents (9,12), as well as in streptozotocin-induced diabetic animals (13,14). Importantly, the drates (CHO) are the major determinants of postprandial glucose levels (22), and low CHO diets have been reanimals in these previous studies were insulin free throughout the study periods in the absence of immunoported to lower postprandial glucose levels directly, as well as indirectly over time by way of weight loss (6). suppression. Eventually, blood glucose levels did increase over time, with islet macrobead recipients becomEvidence from clinical and metabolic studies demonstrates aggravation of glycemic control and dyslipidemia ing mildly hyperglycemic. They continued, however, to show evidence of improved control of their diabetic in diabetic patients with a high-carbohydrate diet (6,7, 10), whereas a low-carbohydrate diet may reverse these state as evidenced by weight gain, lack of ketotic episodes, lack of polyuria, and improved responses to gluserious metabolic abnormalities (4). In the study reported here, we have evaluated the efcose loading.
The rise in serum glucose levels, as well as histologifect of carbohydrate restriction on the function of porcine islet macrobeads implanted in rats with streptozocal examination of the porcine islet macrobeads after implantation indicates the in vivo loss of islet cells, intocin-induced diabetes over a period of 333 days in a test of the hypothesis that dietary carbohydrate restriccluding β-cells, over time despite the protective macrobead environment. This fact prompted us to look at this tion, by virtue of the reduced metabolic stress on the islets, would lead to improved preservation of β-cell phenomenon of β-cell loss and ask whether anything can be done to reduce it. mass and/or improved glucose homeostasis, as evidenced by serum glucose levels and elimination of exogenous As substantial bodies of data indicate, following implantation, porcine islet macrobeads function dynamiinsulin requirements. cally, responding to changing demands for insulin in re-MATERIALS AND METHODS sponse to factors such as weight gain and carbohydrate Animals load. There are limitations to this responsiveness, however, in that, if insulin production and secretion are alInbred male Wistar Furth rats (Harlan Sprague Dawley, Indianapolis IN), aged 5-6 weeks on arrival, were ready maximal, the implanted islets will not be able to meet still greater demands. For example, Unger and maintained on a 12-h light/dark cycle (lights on 0700 h) in a temperature/humidity-controlled room. Rats were Grundy have reported that hyperglycemia may be provoked by an environmental perturbation that increases housed individually per cage in poly-sulfone cages, 483 × 267 × 203 mm (L × W × H), with a rim wire lid and insulin demand and/or decreases insulin supply in a previously normoglycemic individual whose β-cells are alpolyester filter tops (Allentown Caging Equipment Co., Inc., Allentown, NJ) within a Micro-FLO Environmental ready secreting at a maximal level (21). What may be even more important is the fact that such hyperglycemia, Systems High Efficiency Particulate Class 100 Air (HEPA) cabinet (Allentown Caging Equipment Co., Inc.). if it is sustained over time, can negatively affect β-cell survival following islet transplantation (15,16). In fact, Room temperature was maintained within 18-26°C with a relative humidity of 30-70%. All animals had free acin vitro incubation of islets and isolated β-cells with glucose induces a process of apoptotic β-cell death that is cess to food and clean tap water (Xenia, OH). All study protocol procedures were approved by The Rogosin Instiglucose concentration dependent (5) . Increased insulin demand can be met through compensatory hypersecretute Animal Care and Use Committee (TRIACUC). After macrobead implantation, rats were maintained tion to a point, but any β-cell loss will put a considerable strain on the surviving cells and thus begin a cycle of on either of two types of purified diet (Test Diet, Division of LabDiet a Purina Mills, Richmond, IN): #T57: progressive metabolic deterioration. Based on these data, it seems reasonable to conclude that reducing the 20% energy from carbohydrates (low-CHO diet: 67.79% energy from protein and 11.99% energy from fat) or demands on implanted islets, whether in an agarose macrobead or not, is likely to preserve islet mass and #T56: 64% energy from carbohydrates (regular-CHO diet: 24.08% energy from protein and 11.97% energy function over the long term.
Because carbohydrates are the major stimulants of infrom fat). Each experimental diet was consumed for 333 days. sulin production and release (2), and thus a major factor
Diabetes Induction
lin secretion of 43 mU/macrobead/24 h. Empty macrobeads implanted into the control rats were 5 weeks of age. Rats were anesthetized with isoflurane, then injected Animals were anesthetized with a mix of 2 ml ketaintravenously (tail vein) with 65 mg/kg streptozotocin mine, 1 ml xylazine, and 0.3 ml butorphanol (ketamine (VWR, West Chester, PA) dissolved in sodium acetate 100 mg/ml, xylazine 20 mg/ml, and butorphanol 10 mg/ buffer (pH 4.5) for diabetes induction. Following the adml) (Fort Dodge Animal Health, Fort Dodge, IA; Ben ministration of streptozotocin, animals exhibited a sigVenue Laboratories, Bedford, OH; Baxter Healthcare nificant loss of body weight, polyuria, polydipsia, and Corporation, Deerfield, IL, respectively) at a dose of hyperglycemia. Diabetes was clinically confirmed with 1.0-1.5 ml/kg (60 mg/ml ketamine, 6 mg/ml xylazine, blood glucose readings of >27 mmol/L for 2-3 consecand 3 mg/ml butorphanol) given intramuscularly. utive days. Rats were started and maintained on proDuring the implantation surgery, macrobeads were tamine-zinc insulin (PZI Insulin, Blue Ridge Pharmgently placed into the peritoneal cavity by use of a steraceuticals, Inc., Greensboro, NC) prior to macrobead ile plastic spoon (Scienceware, Pequannock, NJ). Musimplantation.
culature was closed with 2.0 metric Polymend ES suExperimental Groups tures (VPL, Phoenix, AZ) and skin was closed with Autoclip wound clips (Becton Dickinson Primary Care After diabetes was confirmed and daily exogenous Diagnostics, Sparks, MD). insulin requirements determined, the animals were randomly assigned to four groups-group 1: 20% lowClinical Observations CHO diet implanted with empty macrobeads (20% CHO Clinical observations from individual animals were control, n = 5); group 2: 20% low-CHO diet implanted recorded daily. Observations included general condition with porcine islet macrobeads (20% CHO PIM, n = 6);
(good, fair, or poor), body weight, nonfasting blood glugroup 3: 64% regular-CHO diet implanted with empty cose (Accu-Chek Simplicity TM BG monitor and Chemmacrobeads (64% CHO control, n = 5); group 4: 64% strips, Roche Diagnostics), urine glucose, and urine keregular-CHO diet implanted with porcine islet macrotones (Keto-Diastix Bayer, Elkhart, IN). Food and beads (64% CHO PIM, n = 5). Scheduled sacrifice ocwater intakes were monitored only during the weekdays curred on day 333 post-macrobead implantation. Two (an average value was obtained for the weekend). Blood animals from group 1 were euthanized shortly after macsamples from the saphenous vein (300-450 µl) were robead implantation due to deteriorating body condition.
collected monthly in microcentrifuge tubes, stored at One animal from each groups were euthanized before room temperature for 30 min then centrifuged, and the the scheduled necropsy. However, in some cases this serum collected. Samples were stored at −70°C for subhappened close to the study termination and the data sequent insulin and C-peptide analysis. obtained to that point were used for interpretation.
Insulin, Glucagon, and Porcine C-Peptide Assays Islet Isolation
Nonfasting blood for the detection of insulin and porDonor islets were prepared from Newsham sows that cine C-peptide was collected monthly throughout the were over 2 years of age and had a history of multiple study. parities as previously described (8) . Islet counts were Standard radioimmunoassays from Linco Research, expressed as equivalent islet numbers (EIN), based on a Inc. (St. Charles, MO) were used for the detection of standard islet size of 150 µm, and 500 EIN were encapinsulin (sensitivity of 2 µU/ml), glucagon (sensitivity of sulated in agarose-agarose macrobeads as previously 20 pg/ml), and porcine C-peptide (sensitivity of 0.1 ng/ described (8).
ml). All samples were frozen at −20°C prior to assay Porcine Islet Macrobead Implantation and were run with samples in duplicate, and reference standards and controls in triplicate. Macrobeads were collected the day prior to implant and stored overnight at room temperature (19-27°C) in
Oral Glucose Tolerance Tests RPMI + 1% A/A. Immediately prior to implant, macrobeads were washed three times with RPMI + 1% A/A.
Oral glucose tolerance tests (OGTT) were performed using 50% dextrose in sterile water at a dose of 1.0 g All animals received an implant of either islet macrobeads at a dose equivalent to 1.0 times daily insulin redextrose/kg body weight. An oral bolus of dextrose (1 g/kg, 50% dextrose injection, USP, Baxter, Deerfield, quirements (45.8 ± 3.0 macrobeads) with an average total weight of 12.0 ± 1.0 g or a comparable number of IL) was administered to nonanesthetized rats with a 16-gauge curved gavage needle (Ejay International, Glenempty macrobeads (47.35 ± 5.7 EM) with an average weight of 14.5 ± 1.7 g. The mean age of the islet macrodora, CA) shortly after macrobead implantation on day 5 and again on day 181 and on day 314. Venous tail beads at implantation was 8 weeks with an average insu-blood samples were obtained for determination of blood culations resulting in probability values of p < 0.05 were considered statistically significant. glucose values at −5, 15, 30, 60, and 90 min relative to the glucose bolus administration (0 min).
RESULTS

Means and SDs were calculated for all dependent
Insulin Requirements measures. Glucose area under the curve (AUC) was calculated using the total AUC with respect to ground
The average daily insulin requirements of each rat method (20) . To determine if there were any significant were established over a 16-day period (1.8 ± 0.15 U/day differences between groups, the original values were en-PZI Insulin) following diabetes induction. tered into a Student t-test.
For all animals receiving islet macrobeads, insulin therapy was discontinued beginning on the day of transNecropsy plantation. They received no exogenous insulin for the Necropsies were performed on day 333 post-macroduration of the study, regardless of which diet they were bead induction (352 days post-streptozotocin induction)
receiving. for 15 of 21 animals. Weights of liver, kidneys, and Following empty macrobead implantation, average spleen were recorded and macrobeads were collected in exogenous insulin requirements over the entire implana sterile fashion and randomly selected for histopatholtation period were 1.72 ± 0.38 U/day insulin (5% deogy or for in vitro culture to assess islet hormone procrease from baseline) for the 20% CHO diet group and duction (insulin, glucagon, and porcine C-peptide).
1.89 ± 0.50 U/day insulin (5% increase over baseline) for the 64% CHO diet group (p < 0.05).
Histopathology
Blood Glucose At necropsy, the following tissues were collected and fixed in 10% neutral buffered formalin for 24 h followed After streptozotocin administration, rats became hyperglycemic with average blood glucose levels of by storage in 70% ETOH: eyes, brain, heart, spleen, liver, kidneys, brain, testes, lungs, diaphragm, pancreas, 25.33 ± 0.31 mmol/L for the 14-day period immediately prior to transplantation. Mean plasma glucose concentraabdominal musculature, sciatic nerve. All histopathology was performed by Pathology Associates Internation declined to 7.92 ± 0.68 mmol/L during the first 7 days posttransplantation for those rats receiving islet tional (PAI, A Charles River Company; West Chester, OH). Tissues were embedded in paraffin, and 5-µm secmacrobeads regardless of CHO group (p < 0.001). The control groups demonstrated hyperglycemia throughout tions were stained with hematoxylin and eosin (H&E). Samples were analyzed by a Diplomat of the American the remainder of the study.
The daily blood glucose values of all porcine islet College of Veterinary Pathology, and the macroscopic and histopathological findings documented. Where apmacrobead recipients gradually increased over the first 60 days posttransplantation. While the 20% CHO group propriate, findings received a severity grade based upon a scale where: N = tissue within normal histological limstabilized at this time, the blood glucose values of the 64% CHO group continued to increase gradually over its, 1 = minimal, 2 = mild, 3 = moderate, and 4 = marked.
the next 200 days. Their food and water intake increased Porcine Islet Macrobead Cell Mass in parallel with this rise in blood glucose levels. For animals receiving empty macrobeads, the 20% Porcine islet macrobeads (PIM) retrieved at necropsy were fixed in 10% formalin overnight and then stored in CHO diet lowered the average blood glucose values over the entire implantation period to a statistically sig-70% ethanol until further treatment. Five porcine islet macrobeads per animal were embedded in paraffin, secnificant level compared to the 64% CHO control group (14.94 ± 0.41 vs. 16.26 ± 0.42 mmol/L, respectively, tioned at 5 µm, and stained with H&E. Cell nuclei from two slides containing five porcine islet macrobead secp < 0.001). For those animals that received islet macrobeads, the 20% CHO diet also significantly lowered the tions were counted at 400× magnification using light microscopy, averaged, and considered as one separate average blood glucose levels compared to animals maintained on the 64% CHO diet (12.88 ± 0.39 vs. 15.57 ± observation with each observation representing an individual animal.
0.86 mmol/L, respectively, p < 0.001) (Fig. 1) . Blood glucose variations expressed as percentage Statistics of baseline were calculated for each group using the following formula: x %V BG = 100 × (BG Ti − BG T0 )/BG T0 , Statistical analysis was performed using Microsoft Excel (Redmond, WA), StatSoft Statistica (Tulsa, OK), where %V BG variation is blood glucose at time of determination expressed in percentage of baseline, BG Ti is and data plotting was performed using Systat Software, Inc.-SigmaPlot 2001 (Point Richmond, CA). The data absolute blood glucose value at time i, and BG T0 is the baseline blood glucose value before streptozotocin inwere analyzed using Student's t-test and ANOVA. Cal- 
duction. The 20% CHO diet induced a significantly
Body Weight lower mean blood glucose variation for animals that reOverall, the 64% CHO diet promoted weight gain on ceived islet macrobeads, compared to animals mainall animals independent of the macrobead type (64% tained on the 64% CHO diet (134.4 ± 42.3% vs. 185.7 ± CHO CTR 393.6 ± 44.3 g vs. 20% CHO CTR 364.15 ± 64.2%, respectively, p < 0.05). A similar situation was 0.77g and 64% CHO PIM 352.8 ± 27.4 g vs. 20% CHO observed for animals receiving empty macrobeads, PIM 332.2 ± 25.31 g at sacrifice, p < 0.05). Regardless where the 20% CHO diet group had a lower mean blood of the experimental group, all animals exhibited good glucose variation compared to the 64% CHO control body conditions for the duration of the experiment, indigroup (172.0 ± 26.0% vs. 192.7 ± 32.1%, respectively, cating that their general health was satisfactory. p < 0.05).
Oral Glucose Tolerance Test Food Intake
The animals underwent a preimplant oral glucose tolerance test (OGTT) to confirm the clinical diagnosis of Food consumption was monitored daily (Fig. 2) . Islet diabetes on day −22. At this time the AUC G was 518.2 macrobead recipients fed the 20% CHO diet maintained mmol L −1 h −1 . A second preimplant OGTT was pera lower average food intake during the experiment comformed on day −9 prior to macrobead implantation but pared to that of the animals fed the 64% CHO (14.66 ± after streptozotocin induction of diabetes. An AUC G of 0.43 vs. 20.13 ± 0.74 g/day, respectively, p < 0.0001).
2819.6 mmol L −1 h −1 was recorded at that time. Control rats that received empty macrobeads and were Following macrobead implantation, the ability of the maintained on the 20% CHO diet also demonstrate a islet macrobeads to respond to a glucose challenge was significantly reduced food intake compared to that of the maintained throughout the study period (Fig. 4) . Al-64% CHO diet group (15.26 ± 0.22 vs. 16.94 ± 0.53 g/ though all islet macrobead-implanted study animals day, respectively, p < 0.001).
eventually became moderately hyperglycemic, OGTTs Water Intake performed over the course of the study continued to demonstrate an initial rise in blood sugar, followed by a As shown in Figure 3 , average daily intake of water for diabetic Wistar Furth rats implanted with empty return to baseline glycemia over 90 min. Diet did not affect glucose tolerance on day 5 postmacrobeads and fed either a 20% or 64% CHO diet was significantly different (42.12 ± 0.68 and 32.53 ± 1.69 transplantation (20% CHO diet 672.7 mmol L −1 h −1 vs. 64% CHO diet 770 mmol L −1 h −1 ) as reflected by the ml/day, respectively, p < 0.05). Diabetic rats implanted with islet macrobeads and maintained on a 64% CHO AUC G . Statistically significant differences, however, were observed for the porcine islet macrobead-implanted diet consumed significantly more water per day than islet macrobead implanted rats fed a 20% CHO diet animals on days 181 (20% CHO diet 1440.0 mmol L CHO diet 1492.6 mmol L −1 h −1 , p < 0.05). The 20% bead implantation, or from any empty macrobead recipients throughout the study. In contrast, porcine C-peptide CHO diet group experienced in general a delayed glucose response after OGTT. Additionally, no significant was routinely detected in the serum of islet macrobeadimplanted rats. Average serum C-peptide levels from 10 differences in the total AUC G were observed for the EM groups, regardless of diet, except on day 5 posttransreadings between 9 and 333 days posttransplantation did not differ between the rats maintained on a 64% CHO plantation when the 20% CHO group had a lower AUC G (20% CHO diet 1436.8 mmol L −1 h −1 vs. 64% CHO diet diet (0.58 ± 0.10 ng/ml) and rats maintained on a 20% CHO diet (0.47 ± 0.12 ng/ml, p > 0.05).
mmol L
, p < 0.05).
Serum C-Peptide Levels Retrieved Porcine Islet Macrobead
Hormone Production Blood was collected monthly from study rats to assess for the presence of porcine C-peptide. Porcine CInsulin, glucagon, and C-peptide were detected in the culture media from PIM retrieved from all study animals peptide was not detected in any animal prior to macro- at necropsy. To establish a reliable assessment for the intake values under similar conditions than animals maintained on the 64% CHO diet. These results were retrieved porcine islet macrobead insulin production, the macrobeads were maintained in culture for 7 weeks. Inobserved under conditions of increased secretory demand (growth), and this pattern persisted even as islet sulin production per macrobead was decreased by 45% in animals fed a 64% CHO diet (43 mU/macrobead premacrobead recipients became moderately hyperglycemic. Significant levels of porcine C-peptide were found implantation; 23.51 ± 6.0 mU/macrobead posttransplantation). Retrieved macrobead insulin production was in the serum of islet macrobead-implanted animals throughout the study, confirming long-term islet macroreduced by 63% (43 mU/macrobead preimplantation; 15.33 ± 6.0 mU/macrobead posttransplantation) in anibead function. In contrast, rats that received empty macrobeads required daily insulin injections and had no evimals maintained on the 20% CHO diet.
dence of porcine C-peptide.
Histopathology
We hypothesized that chronic in vivo exposure of porcine islet macrobeads to hyperglycemia might affect With the exception of the expected mild to moderate pancreatic inflammation associated with this streptozothe preservation of islet cell mass or the development of secretory defects. However, no significant differences tocin-induced diabetes animal model, inflammation, fibrosis, and/or hypertrophy/hyperplasia of the peritowere observed in the levels of circulating serum porcine C-peptide. Furthermore, no significant differences in neum covering the pancreas, abdominal wall, and/or diaphragm were thought to be related to the presence of hormone production levels or macrobead β-cell mass were found for the islet macrobeads retrieved at necthe macrobeads. This response was minimal to mild in degree. The changes seen were not thought to have alropsy when the two carbohydrate diets were compared. We take the lack of islet macrobead differences betered the normal function of the tissues/organs concerned. No clear differences among the groups were tween the low and high CHO groups in terms of β-cell mass, serum porcine C-peptide levels, and insulin proidentified.
Macroscopically, the peritoneal cavities of the rats duction from retrieved macrobeads to be evidence of equivalent islet macrobead function. However, the appeared normal. The only significant finding during necropsy that was confirmed by histological exam was marked differences in food/water intake, blood glucose levels, and OGTT data for the 20% CHO PIM group are the development of atypical renal tubule hyperplasia (2/ 8 animals from the control group and 3/12 animals from consistent with the notion that the effects of the lower CHO diet lie downstream of insulin secretion. the PIM group), renal tubule adenoma (2/8 animals from the control group and 2/12 animals from the PIM Our data demonstrate a correlation between low to moderate hyperglycemia and a low intake of the 20% group), and renal tubule carcinoma (5/8 animals from the control group and 6/12 animals from the PIM CHO diet. This decreased consumption may be due to various mechanisms. For example, a higher protein diet group). These findings are highly correlated with the mutagenic and cytotoxic streptozotocin that was used for could have increased satiety and reduced hunger following ingestion without conditioned taste aversion (1). Aldiabetes induction, as previously reported by others (3, 11, 17, 19) .
ternatively, and the mechanism that we favor, is that the insulin sensitivity of recipient animals maintained on the Macrobead Islet Cell Mass low carbohydrate diet was at least preserved. In our study, a much higher intake of the 64% CHO diet, even Interestingly, total islet cell mass did not appear to differ as an average of 204.7 ± 40.6 cells were counted in the presence of hyperglycemia, demonstrates a pronounced reduction in insulin sensitivity without a signiffrom macrobead sections retrieved from the 20% CHO group while 159.2 ± 13.3 cells were counted from secicant alteration in insulin secretion (as extrapolated from serum porcine C-peptide values). In fact, the number of tions retrieved from the 64% CHO group (p > 0.05). The data were normally distributed with no statistical β-cells in the retrieved macrobeads from the higher CHO group is similar to the mass from the 20% CHO significance between groups (p > 0.05).
group. Furthermore, the functional capacity of the 64% DISCUSSION CHO islet macrobead group is 50% or more of the 20% carbohydrate islet macrobead group, as shown by reThe results of this study demonstrate that following the transplantation of porcine islet macrobeads, rats fed trieved macrobeads' insulin and C-peptide data. These findings emphasize that postprandial glucose a 20% CHO diet had significantly lower daily blood glucose values and less daily variation, expressed as perlevels are primarily determined by the amount of ingested carbohydrates and that a low-carbohydrate diet centage of baseline, when compared to those in rats fed a regular diet containing 64% CHO. In fact, animals improves insulin/glucose ratios. Whether similar improvements in glycemic control can been achieved by maintained on the 20% CHO diet, regardless of the type of macrobeads implanted, also had lower food and water increasing the number of islet macrobeads to account 
